These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 21619854)

  • 1. Collaborative study on influenza vaccine clinical trial serology - part 1: CHMP compliance study.
    Wood JM; Newman RW; Daas A; Terao E; Buchheit KH
    Pharmeur Bio Sci Notes; 2011 Jun; 2011(1):27-35. PubMed ID: 21619854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collaborative study on influenza vaccine clinical trial serology - part 2: reproducibility study.
    Wood JM; Montomoli E; Newman RW; Daas A; Buchheit KH; Terao E
    Pharmeur Bio Sci Notes; 2011 Jun; 2011(1):36-54. PubMed ID: 21619855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calibration of the Ph. Eur. Biological Reference Preparation (BRP) for tetanus vaccine (adsorbed) batch 3.
    Tierney R; Hockley J; Rigsby P; Terao E; Daas A; Buchheit KH; Sesardic D
    Pharmeur Bio Sci Notes; 2011 Jun; 2011(1):1-26. PubMed ID: 21619853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing the reproducibility of serological methods used to evaluate immunogenicity of pandemic H1N1 influenza vaccines-an effective EU regulatory approach.
    Wagner R; Göpfert C; Hammann J; Neumann B; Wood J; Newman R; Wallis C; Alex N; Pfleiderer M
    Vaccine; 2012 Jun; 30(27):4113-22. PubMed ID: 22446639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reproducibility of serology assays for pandemic influenza H1N1: collaborative study to evaluate a candidate WHO International Standard.
    Wood JM; Major D; Heath A; Newman RW; Höschler K; Stephenson I; Clark T; Katz JM; Zambon MC
    Vaccine; 2012 Jan; 30(2):210-7. PubMed ID: 22100887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collaborative study for the standardisation of the histamine sensitizing test in mice and the CHO cell-based assay for the residual toxicity testing of acellular pertussis vaccines.
    Xing D; Maes A; Behr-Gross ME; Costanzo A; Daas A; Buchheit KH
    Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):51-63. PubMed ID: 20223190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of global capacity to conduct tuberculosis drug development trials: do we have what it takes?
    van Niekerk C; Ginsberg A
    Int J Tuberc Lung Dis; 2009 Nov; 13(11):1367-72. PubMed ID: 19861008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International collaborative study to establish reference preparations to standardise haemagglutination testing for anti-A and anti-B in normal intravenous immunoglobulins by the direct method.
    Thorpe SJ; Fox B; Sharp G; Heath AB; Behr-Gross ME; Terao E; Virata-Theimer ML; Yu MW
    Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):39-50. PubMed ID: 20223189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Registration of influenza vaccines for children in Europe.
    Granström M; Voordouw AC
    Vaccine; 2011 Oct; 29(43):7572-5. PubMed ID: 21820474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collaborative study for the establishment of the Ph. Eur. BRP for oral poliomyelitis vaccine (OPV) Batch 3 for use in the potency assay.
    Buchheit KH; Daas A; Stalder J
    Pharmeuropa Spec Issue Biol; 2002 Jun; 2002(1):67-91. PubMed ID: 12448032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of correlates of immunity in European Union licensing of influenza vaccines.
    Wood JM; Newman RW; Ploss K
    Dev Biol (Basel); 2003; 115():9-16. PubMed ID: 15088770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calibration of European pharmacopoeia biological reference preparation for diphtheria vaccine (adsorbed) batch 4.
    Stickings P; Rigsby P; Buchheit KH; Sesardic D
    Pharmeur Bio Sci Notes; 2009 Oct; 2009(1):1-9. PubMed ID: 20144448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative study on safety and immunogenicity between influenza subunit vaccine and split vaccine].
    Dong PM; Li YQ; Zheng TZ; Jia YP; Li F; Han TW; Qiao RX; Zhang BH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jul; 24(7):570-3. PubMed ID: 12975010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of a biological reference preparation for hepatitis A vaccine (inactivated, non-adsorbed).
    Stalder J; Costanzo A; Daas A; Rautmann G; Buchheit KH
    Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):15-29. PubMed ID: 20223187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calibration of replacement international standard and European pharmacopoeia biological reference preparation for tetanus toxoid, adsorbed.
    Sesardic D; Winsnes R; Rigsby P; Tierney R; Gaines-Das R
    Biologicals; 2002 Mar; 30(1):49-68. PubMed ID: 11846430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of serological trials submitted for annual re-licensure of influenza vaccines to regulatory authorities between 1992 and 2002.
    Voordouw AC; Beyer WE; Smith DJ; Sturkenboom MC; Stricker BH
    Vaccine; 2009 Dec; 28(2):392-7. PubMed ID: 19878750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical data on Fluarix: an inactivated split seasonal influenza vaccine.
    El Sahly HM; Keitel WA
    Expert Rev Vaccines; 2008 Aug; 7(6):713-9. PubMed ID: 18665769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and immunogenicity of an influenza vaccine A/H5N1 (A/Vietnam/1194/2004) when coadministered with a heat-labile enterotoxin (LT) adjuvant patch.
    Glenn GM; Thomas DN; Poffenberger KL; Flyer DC; Ellingsworth LR; Andersen BH; Frech SA
    Vaccine; 2009 Dec; 27 Suppl 6():G60-6. PubMed ID: 20006142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety, tolerability and immunogenicity of a mammalian cell-culture-derived influenza vaccine: a sequential Phase I and Phase II clinical trial.
    Groth N; Montomoli E; Gentile C; Manini I; Bugarini R; Podda A
    Vaccine; 2009 Jan; 27(5):786-91. PubMed ID: 19027046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collaborative study for the validation of alternative in vitro potency assays for human tetanus immunoglobulins.
    Gross S; Janssen SW; de Vries B; Terao E; Daas A; Buchheit KH
    Biologicals; 2010 Jul; 38(4):501-10. PubMed ID: 20399681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.